Bacil Pharma Ltd share price logo

Bacil Pharma Share Price

BSE: 524516

Small Cap

Healthcare Sector

₹42.94

-1.47

(-3.31%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Bacil Pharma Stock Performance

as on January 21, 2026 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹42.20
    ₹44.99
    downward going graph

    1.72%

    Downside

    4.77%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹26.69
    ₹47.90
    downward going graph

    37.84%

    Downside

    11.55%

    Upside

    downward going graph

Bacil Pharma share price movements today

Previous Close
₹44.41
Open
₹44.99
Volume
434.00
Upper Circuit
₹46.63
Lower Circuit
₹42.19
Day's Low - High
₹42.20 - ₹44.99
52 Week Low - High
₹26.69 - ₹47.90

Bacil Pharma Historical Returns

1 Month Return
+ 18.88 %
3 Month Return
+ 5.12 %
1 Year Return
-0.56 %
3 Year Return
+ 432.09 %
5 Year Return
+ 689.34 %

Bacil Pharma Fundamentals

as on January 21, 2026 at 4:01 pm IST

Market Cap

₹61.63 Cr

Return on Equity (ROE)

-0.98

PE Ratio (TTM)

0

Return on capital employed (ROCE)

-1.04

Beta (LTM)

0.21

P/B Ratio

2.33

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-97.92

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

Bullish

View Technical Analysis

Bacil Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bacil Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA61.63137.87%0.00-1NA
Advanced Enzyme Technologies Ltd image
Advanced Enzyme Technologies Ltd
BUY3,051.12-2.35%0.53133636
Windlas Biotech Ltd image
Windlas Biotech Ltd
NA1,669.5318.91%0.5360759
Amwill Health Care Ltd image
Amwill Health Care Ltd
NA81.11-11.3%0.001040
Gufic BioSciences Ltd image
Gufic BioSciences Ltd
NA3,129.8232.97%0.6969819
See all

Bacil Pharma Share Price Target

Get share price movements and forecasts by analysts on Bacil Pharma.

Source: S&P Global Market Intelligence

Bacil Pharma Stock’s Investor Sentiment and Interest

Search interest for Bacil Pharma Ltd Stock has increased by 29% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:29% versus previous 30 day period

Bacil Pharma Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Other Income
0.01
0.05
0.03
0.03
0.02
0.01
0.56
-
0.09
1
0.05
Total Income
0.01
0.05
0.03
0.03
0.02
0.01
0.56
-
0.09
1
0.05
Expenses
0.08
0.03
0.04
0.06
0.06
0.04
0.07
0.06
0.07
0.11
0.04
Operating Profit
-0.08
-0.03
-0.04
-0.06
-0.06
-0.04
-0.07
-0.06
-0.07
-0.11
-0.04
Profit Before Interest, Tax and Depreciation
-0.08
0.02
-0.01
-0.02
-0.04
-0.03
0.49
-0.06
0.02
0.89
0.02
Profit Before Tax
-0.08
0.02
-0.01
-0.02
-0.04
-0.03
0.49
-0.06
0.02
0.89
0.02
Tax Paid
-
-
-
-
-
-
-
-
-
0.22
-
Profit After Tax
-0.08
0.02
-0.01
-0.02
-0.04
-0.03
0.48
-0.06
0.02
0.67
0.01
Total Net profit including share of profit / Loss from associate company
-0.08
0.02
-0.01
-0.02
-0.04
-0.03
0.48
-0.06
0.02
0.67
0.01
EPS
-0.13
0.03
-0.02
-0.04
-0.07
-0.06
0.82
-0.1
0.03
0.48
0.01
Actual EPS
-0.13
0.03
-0.02
-0.04
-0.07
-0.06
0.82
-0.1
0.03
0.48
0.01
Adjusted EPS
-0.13
0.03
-0.02
-0.04
-0.07
-0.06
0.82
-0.1
0.03
0.48
0.01
Diluted EPS
-0.13
0.03
-0.02
-0.04
-0.07
-0.06
0.82
-0.1
0.03
0.48
0.01

Bacil Pharma Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Other Income
0.17
0.27
0.09
0.14
0.07
0.06
0.11
0.13
0.66
Total Income
0.17
0.27
0.09
0.14
0.07
0.06
0.11
0.13
0.66
Expenses
0.17
4.02
0.43
0.45
0.31
3.91
0.21
0.19
0.25
Operating Profit
-0.17
-4.02
-0.43
-0.45
-0.31
-3.91
-0.21
-0.19
-0.25
Profit Before Interest, Tax and Depreciation
-
-3.74
-0.33
-0.31
-0.23
-3.86
-0.1
-0.06
0.41
Depreciation
-
0.01
0.01
0.01
-
-
-
-
-
Profit Before Tax
-
-3.75
-0.34
-0.32
-0.23
-3.86
-0.1
-0.06
0.41
Profit After Tax
-
-3.75
-0.34
-0.32
-0.24
-3.86
-0.1
-0.06
0.4
Total Net profit including share of profit / Loss from associate company
-
-3.75
-0.34
-0.32
-0.24
-3.86
-0.1
-0.06
0.4
EPS
-
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.1
0.69
Actual EPS
-
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.1
0.69
Adjusted EPS
-
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.1
0.69
Diluted EPS
-
-6.37
-0.58
-0.54
-0.41
-6.55
-0.17
-0.1
0.69

Bacil Pharma Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
0.06
-
1.44
-0.3
-0.38
-0.4
-4.01
-0.15
-
0.4
Cash Flow from Investing Activities
-2.71
0.03
-1.2
0.28
0.39
0.53
3.81
-0.12
0.08
0.34
Cash Flow from Financing Activities
-
-
-
-0.16
-0.06
-0.07
0.33
0.06
-0.06
2.08
Net Cash Flow
0.01
0.02
0.23
-0.18
-0.05
0.06
0.13
-0.2
0.01
2.82

Bacil Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Bacil Pharma.

  • Bacil Pharma Ltd Earnings Results

    Bacil Pharma Ltd’s net profit fell -97.92% since last year same period to ₹0.01Cr in the Q2 2025-2026. On a quarterly growth basis, Bacil Pharma Ltd has generated -98.51% fall in its net profits since last 3-months.

    Read More about Earnings Results

Insights on Bacil Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, Bacil Pharma stock has moved up by 23.0%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, Bacil Pharma has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 0.08% of holdings in Sep 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 26.0% return, outperforming this stock by 21.8%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 99.92% of holdings in Sep 2025 quarter

About Bacil Pharma Ltd

Incorporated as a private limited company in Maharashtra in May 87 Bacil Pharma BPL was converted into a public limited company in Oct.90. The main business activity of the Company is Pharmaceutical.Bal Pharma is a fully integrated and leading Indian pharmaceutical company specialized in Prescription drugs Branded Formulations APIs Generic OTC products Intravenous Infusions and Bulk Drugs. Domestic operations are spread across pan India. The company has strong field force of 500 plus spread over various States and Districts. It has a strong distribution set up with Super Stockist in all the States and stockists for retail coverage. To augment the domestic market Companys operations are based on focused approach.MultiSpeciality division Vibrant specialises in various specialties like AntiInfectives Pain Management Respiratory Care Womens Health to name a few. Aziwin Ebay Balvibe MNF Ocium and Monogesic Plus Gel Innovative Pain Relieving Gel first time in India are some of the leading brands in the respective segments. Bal Vedics Division integrates modern medicine with herbal/ayurvedic preparation targeting specific conditions like Prostrate Enlargement Renal Calculi Male Infertility Women Health etc. Bal Pharma Institutional division is associated with the top Government bodies and Hospitals to extend its product range to the masses. Every area is well covered and supplied through there channel partners.Bal Pharma Unit 1 is a finished dosage facility for manufacturing Tablets and Capsules. Bal Pharma Unit 2 is involved in the manufacturing of APIs. A wellequipped RD laboratory a good Kilo laboratory and quality control facilities form the other spheres of activity here. Bal Pharma Unit 3 is a finished dosage facility for manufacturing Intravenous Fluids Ophthalmic Preparations Liquid Oral Preparations. BPL came out with a public issue of Rs 7 cr in Mar.94 to set up a plant at Vapi to manufacture bulk drugs like atenalol norfloxacin pefloxacin and ciprofloxacin. The company entered into a marketing arrangement with a distributor Kam Han Industries Hong Kong to export 50 of the production. Due to various reasons the civil works at Vapi were affected. However to avoid further delay in project implementation the company acquired from SICOM an existing bulk drug unit with necessary infrastructure and production facilities at Lote Parashuram near Ratnagiri..

Revenue: ₹0.00Cr as on September 2025 (Q2 FY26)
Net Profit: ₹0.01Cr as on September 2025 (Q2 FY26)
OrganisationBacil Pharma Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Bacil Pharma share price today?

Bacil Pharma share price today stands at ₹42.94 as on at the close of the market. Bacil Pharma share today touched a day high of ₹44.99 and a low of ₹42.2.

What is the 52 week high and 52 week low range for Bacil Pharma share?

Bacil Pharma touched a 52 week high of ₹47.9 and a 52 week low of ₹26.69. Bacil Pharma share price today i.e. is closed at ₹42.94, which is -10.35% down from its 52 week high and 60.88% up from its 52 week low.

What is Bacil Pharma's market capitalisation today?

Bacil Pharma market capitalisation is ₹61.63 Cr as on .

How to buy Bacil Pharma shares?

To buy Bacil Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for 524516 or Bacil Pharma Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Bacil Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Bacil Pharma trading volume today?

Bacil Pharma trading volume is 434.00 as on . This means that 434.00 shares of Bacil Pharma were bought and sold on the stock market during today's trading session.